<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38156079</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7074</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>International journal of general medicine</Title><ISOAbbreviation>Int J Gen Med</ISOAbbreviation></Journal><ArticleTitle>Coagulation Parameters in Post-Covid-19 Condition in Relation to Various Titers of Anti-SARS-CoV-2 IgG in Blood Plasma.</ArticleTitle><Pagination><StartPage>6127</StartPage><EndPage>6135</EndPage><MedlinePgn>6127-6135</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IJGM.S425496</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="UNASSIGNED">Post-COVID-19 condition is thought to affect 10-20% of people at least 3 months after a diagnosis of COVID-19 and two months of symptoms. Post-COVID-19 condition presents itself with many clinical effects with varying degrees of severity ranging from a mild cough to a life-threatening coagulopathy. Our study aimed to identify a relationship between the titers of anti-SARS-CoV-2 IgG and anticoagulation parameters: antithrombin III (ATIII), protein C (PC) and thrombomodulin (TM).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">Blood plasma was collected from healthy donors aged 25-45 who had recovered from COVID-19 3-6 months ago and their titers of anti-SARS-CoV-2 IgG and ATIII, PC, and TM were measured.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We found that concentrations and activities of key anticoagulation parameters (ATIII, PC, and TM) measured in donor plasma during the post-COVID-19 varied in relation to the titers of anti-SARS-CoV-2 IgG.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">While we identified a dysfunction of anticoagulation parameters in patients with post-COVID-19, we aim to explore the subpopulation antibody IgG fraction directly using in vivo and in vitro experiments with the possibility to contribute to the development of treatment options for post-COVID-19 conditions.</AbstractText><CopyrightInformation>&#xa9; 2023 Strubchevska et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Strubchevska</LastName><ForeName>Kateryna</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8330-1180</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rachkovska</LastName><ForeName>Antonina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6908-7357</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krenytska</LastName><ForeName>Daryna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karbovskyy</LastName><ForeName>Vitalii</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, LLS Biopharma-Plasa, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozyk</LastName><ForeName>Marko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Secor</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Oakland University William Beaumont School of Medicine, Auburn Hills, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raksha</LastName><ForeName>Nataliia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vovk</LastName><ForeName>Tetiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savchuk</LastName><ForeName>Olexii</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-3621-6981</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falalyeyeva</LastName><ForeName>Tetyana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4415-9676</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaminsky</LastName><ForeName>Rostyslav</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department Educational-Scientific Center&#xa0;"Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostapchenko</LastName><ForeName>Liudmyla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Int J Gen Med</MedlineTA><NlmUniqueID>101515487</NlmUniqueID><ISSNLinking>1178-7074</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antithrombin III</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">protein C</Keyword><Keyword MajorTopicYN="N">thrombomodulin</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>29</Day><Hour>3</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38156079</ArticleId><ArticleId IdType="pmc">PMC10754419</ArticleId><ArticleId IdType="doi">10.2147/IJGM.S425496</ArticleId><ArticleId IdType="pii">425496</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: a narrative review on potential mechanisms. J Mol Histol. 2020;51(6):613&#x2013;628. doi:10.1007/s10735-020-09915-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10735-020-09915-3</ArticleId><ArticleId IdType="pmc">PMC7533045</ArticleId><ArticleId IdType="pubmed">33011887</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyanka COP, Singh I, Patra G, et al. Aerosol transmission of SARS-CoV-2: the unresolved paradox. Travel Med Infect Dis. 2020;37:101869. PMID: 32891726; PMCID: PMC7471761. doi:10.1016/j.tmaid.2020.101869</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101869</ArticleId><ArticleId IdType="pmc">PMC7471761</ArticleId><ArticleId IdType="pubmed">32891726</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20(1):172. doi:10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Adanma Ezihe-Ejiofor J, Hutchinson N. Anticlotting mechanisms 1: physiology and pathology. Cont Educ Anaesth Crit Care Pain. 2013;13(3):87&#x2013;92. doi:10.1093/bjaceaccp/mks061</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjaceaccp/mks061</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry DJ. Antithrombin and its inherited deficiencies. Blood Rev. 1994;8(1):37&#x2013;55. doi:10.1016/0268-960x(94)90006-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0268-960x(94)90006-x</ArticleId><ArticleId IdType="pubmed">8205009</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin JH, Fern&#xe1;ndez JA, Gale AJ, Mosnier LO. Activated protein C. J Thromb Haemost. 2007;5(Suppl 1):73&#x2013;80. doi:10.1111/j.1538-7836.2007.02491.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02491.x</ArticleId><ArticleId IdType="pubmed">17635713</ArticleId></ArticleIdList></Reference><Reference><Citation>Poh KC, Jia Tay VY, Lin SH, Chee HL, Thangavelautham S. A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population. Singapore Med J. 2022;63(7):350&#x2013;361. doi:10.11622/smedj.2020174</Citation><ArticleIdList><ArticleId IdType="doi">10.11622/smedj.2020174</ArticleId><ArticleId IdType="pmc">PMC9578119</ArticleId><ArticleId IdType="pubmed">33264831</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248&#x2013;254. doi:10.1006/abio.1976.9999</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abio.1976.9999</ArticleId><ArticleId IdType="pubmed">942051</ArticleId></ArticleIdList></Reference><Reference><Citation>Kravchenko O, Melnyk V, Tsarenko T, et al. The blood coagulation tests from ischemic stroke patients with or without type 2 diabetes mellitus. Biomed Res. 2018;29(14):2938&#x2013;2943. doi:10.4066/biomedicalresearch.29-18-332</Citation><ArticleIdList><ArticleId IdType="doi">10.4066/biomedicalresearch.29-18-332</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowther JR. The ELISA guidebook. Methods Mol Biol. 2000;149:III&#x2013;413. doi:10.1385/1592590497</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/1592590497</ArticleId><ArticleId IdType="pubmed">11028258</ArticleId></ArticleIdList></Reference><Reference><Citation>Macarena FK. Antibody validation. Mater Methods. 2016;6:1.</Citation></Reference><Reference><Citation>Godino C, Scotti A, Maugeri N, et al. Antithrombotic therapy in patients with COVID-19? -rationale and evidence. Int J Cardiol. 2021;324:261&#x2013;266. doi:10.1016/j.ijcard.2020.09.064</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.09.064</ArticleId><ArticleId IdType="pmc">PMC7521414</ArticleId><ArticleId IdType="pubmed">33002521</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachkovska A, Krenytska D, Karbovskyy V, et al. Characteristics of products of fibrinogen origin in the presence of anti-SARS-CoV-2 IgG in the bloodstream. Rev Recent Clin Trials. 2022. doi:10.2174/1574887118666221219115856</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574887118666221219115856</ArticleId><ArticleId IdType="pubmed">36537598</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa ACN, Montalv&#xe3;o SAL, Barbosa KGN, et al. Prolonged APTT of unknown etiology: a systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit. Res Pract Thromb Haemost. 2019;3(4):749&#x2013;757. doi:10.1002/rth2.12252</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12252</ArticleId><ArticleId IdType="pmc">PMC6782020</ArticleId><ArticleId IdType="pubmed">31624795</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S. Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults. Am J Clin Pathol. 2013;139(3):370&#x2013;379. doi:10.1309/AJCPC5C4AGFRDKMX</Citation><ArticleIdList><ArticleId IdType="doi">10.1309/AJCPC5C4AGFRDKMX</ArticleId><ArticleId IdType="pubmed">23429374</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratton R, Slapak G, Mahungu T, Kinloch-de Loes S. Autoimmunity and HIV. Curr Opin Infect Dis. 2009;22(1):49&#x2013;56. doi:10.1097/QCO.0b013e3283210006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0b013e3283210006</ArticleId><ArticleId IdType="pubmed">19532080</ArticleId></ArticleIdList></Reference><Reference><Citation>Houen G, Trier NH. Epstein-Barr virus and systemic autoimmune diseases. Front Immunol. 2021;11:587380. doi:10.3389/fimmu.2020.587380</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.587380</ArticleId><ArticleId IdType="pmc">PMC7817975</ArticleId><ArticleId IdType="pubmed">33488588</ArticleId></ArticleIdList></Reference><Reference><Citation>Katrii T, Shandyuk V, Vovk T, et al. Effect of IgG from multiple sclerosis patients on amidolytic activity of coagulation and anticoagulation factors of hemostasis. Biomed Res Ther. 2017;4(08):1502&#x2013;1512. doi:10.15419/bmrat.v4i08.205</Citation><ArticleIdList><ArticleId IdType="doi">10.15419/bmrat.v4i08.205</ArticleId></ArticleIdList></Reference><Reference><Citation>Raksha N, Burlova-Vasylieva M, Torgalo E, Savchuk O. The appearance of molecules of prothrombin origin in blood upon development of atherothrombotic and cardioembolic ischemic stroke. Bull T Shevchenko Nat Univ Kyiv Ser Biol. 2014;68(3):57&#x2013;60. doi:10.17721/1728_2748.2014.68.57-60</Citation><ArticleIdList><ArticleId IdType="doi">10.17721/1728_2748.2014.68.57-60</ArticleId></ArticleIdList></Reference><Reference><Citation>Darmarajan T, Paudel KR, Candasamy M, et al. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation. Environ Sci Pollut Res Int. 2022;29(36):54072&#x2013;54087. doi:10.1007/s11356-022-20984-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-022-20984-7</ArticleId><ArticleId IdType="pmc">PMC9163295</ArticleId><ArticleId IdType="pubmed">35657545</ArticleId></ArticleIdList></Reference><Reference><Citation>Falalyeyeva T, Komisarenko I, Yanchyshyn A, et al. Vitamin D in the prevention and treatment of type-2 diabetes and associated diseases: a critical view during COVID-19 time. Minerva Biotechnol Biomol Res. 2021;33(2):65&#x2013;75. doi:10.23736/S2724-542X.21.02766-X</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S2724-542X.21.02766-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozyk M, Strubchevska K, Marynenko T, et al. Effect of peptides from plasma of patients with coronary artery disease on the vascular endothelial cells. Medicina. 2023;59(2):238. doi:10.3390/medicina59020238</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina59020238</ArticleId><ArticleId IdType="pmc">PMC10003965</ArticleId><ArticleId IdType="pubmed">36837440</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>